Trial
NCT00736294
Prevention of Atrial Fibrillation by Inhibition Conversion Enzyme (ICE) After Radiofrequency Ablation of Atrial Flutter
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Collaborators
Sanofi; Ministry of Health, France; LivaNova
Condition
Atrial Fibrillation
Intervention
Ramipril
Why stopped
Difficulty to include patients
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-07-28